2 studies found for:    17508028 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Intervention: Drug: BIBW 2992 (Afatinib)
2 Recruiting Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.
Condition: Head-and-Neck Squamous Cell Carcinoma
Intervention:

Indicates status has not been verified in more than two years